These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2256478

  • 1. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO, Alaupovic P.
    Am J Nephrol; 1990; 10 Suppl 1():69-75. PubMed ID: 2256478
    [Abstract] [Full Text] [Related]

  • 2. Dyslipidemia and nephrotic syndrome: recent advances.
    Kronenberg F.
    J Ren Nutr; 2005 Apr; 15(2):195-203. PubMed ID: 15827892
    [Abstract] [Full Text] [Related]

  • 3. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.
    Vega GL, Grundy SM.
    Kidney Int; 1988 Jun; 33(6):1160-8. PubMed ID: 3165483
    [Abstract] [Full Text] [Related]

  • 4. Treatment of nephrotic hyperlipoproteinemia with gemfibrozil.
    Groggel GC, Cheung AK, Ellis-Benigni K, Wilson DE.
    Kidney Int; 1989 Aug; 36(2):266-71. PubMed ID: 2779095
    [Abstract] [Full Text] [Related]

  • 5. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J, Vilella E.
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [Abstract] [Full Text] [Related]

  • 6. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG, Kaysen GA, Barrett HA, Stellaard F, Gadellaa MM, Voorbij HA, Reijngoud DJ, Rabelink TJ.
    Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
    [Abstract] [Full Text] [Related]

  • 7. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND, Liang KH.
    Circulation; 2004 Jul 27; 110(4):419-25. PubMed ID: 15262831
    [Abstract] [Full Text] [Related]

  • 8. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M, Anarat A, Bayazit AK, Noyan A, Ozel A, Anarat R, Aydingülü H, Dikmen N.
    Turk J Pediatr; 2002 Jul 27; 44(1):40-4. PubMed ID: 11858378
    [Abstract] [Full Text] [Related]

  • 9. Hyperlipidemia in childhood nephrotic syndrome.
    Thabet MA, Salcedo JR, Chan JC.
    Pediatr Nephrol; 1993 Oct 27; 7(5):559-66. PubMed ID: 8251323
    [Abstract] [Full Text] [Related]

  • 10. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
    Hirano T, Mamo JC, Nagano S, Sugisaki T.
    Nephron; 1991 Oct 27; 58(1):95-100. PubMed ID: 1857487
    [Abstract] [Full Text] [Related]

  • 11. Low-density lipoprotein metabolism in the nephrotic syndrome.
    Warwick GL, Caslake MJ, Boulton-Jones JM, Dagen M, Packard CJ, Shepherd J.
    Metabolism; 1990 Feb 27; 39(2):187-92. PubMed ID: 2299990
    [Abstract] [Full Text] [Related]

  • 12. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
    Wanner C, Krämer-Guth A, Nauck M, Quaschning T, Pavenstädt H, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Feb 27; 22(1-3):39-46. PubMed ID: 8676822
    [Abstract] [Full Text] [Related]

  • 13. Hypocholesterolemic effect of spirulina in patients with hyperlipidemic nephrotic syndrome.
    Samuels R, Mani UV, Iyer UM, Nayak US.
    J Med Food; 2002 Feb 27; 5(2):91-6. PubMed ID: 12487756
    [Abstract] [Full Text] [Related]

  • 14. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M, Salamatullah Q, Ferdous Z, Hussain MA.
    Bangladesh Med Res Counc Bull; 1976 Jun 27; 2(1):64-70. PubMed ID: 190998
    [Abstract] [Full Text] [Related]

  • 15. Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside-nephrotic rats.
    Moritomo Y, Hirano T, Ebara T, Kurokawa M, Naito H, Furukawa S, Nagano S.
    Nephron; 1994 Jun 27; 67(2):218-25. PubMed ID: 8072613
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia.
    Vega GL, Toto RD, Grundy SM.
    Kidney Int; 1995 Feb 27; 47(2):579-86. PubMed ID: 7723244
    [Abstract] [Full Text] [Related]

  • 17. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
    Prata MM, Nogueira AC, Pinto JR, Correia AM, Vicente O, Rodrigues MC, Miguel MJ.
    Clin Nephrol; 1994 May 27; 41(5):277-83. PubMed ID: 8050207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.